47 related articles for article (PubMed ID: 31262553)
1. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.
Arrant AE; Roth JR; Boyle NR; Kashyap SN; Hoffmann MQ; Murchison CF; Ramos EM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Roberson ED
Acta Neuropathol Commun; 2019 Dec; 7(1):218. PubMed ID: 31870439
[TBL] [Abstract][Full Text] [Related]
2. Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features.
Karch CM; Ezerskiy L; Redaelli V; Giovagnoli AR; Tiraboschi P; Pelliccioni G; Pelliccioni P; Kapetis D; D'Amato I; Piccoli E; Ferretti MG; Tagliavini F; Rossi G
Neurobiol Aging; 2016 Feb; 38():215.e1-215.e12. PubMed ID: 26652843
[TBL] [Abstract][Full Text] [Related]
3. Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia.
Sung W; Noh MY; Nahm M; Kim YS; Ki CS; Kim YE; Kim HJ; Kim SH
J Neuroinflammation; 2024 Feb; 21(1):47. PubMed ID: 38347588
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Progranulin Gene Mutations in Portuguese Patients with Frontotemporal Dementia.
Almeida MR; Tábuas-Pereira M; Baldeiras I; Lima M; Durães J; Massano J; Pinto M; Cruto C; Santana I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203682
[TBL] [Abstract][Full Text] [Related]
5. Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias.
Meda F; Simrén J; Borroni B; Cantoni V; Archetti S; Biasiotto G; Andreasson U; Blennow K; Kvartsberg H; Zetterberg H
Clin Chem Lab Med; 2023 Nov; 61(12):2195-2204. PubMed ID: 37476993
[TBL] [Abstract][Full Text] [Related]
6. Genetic screen in a large series of patients with primary progressive aphasia.
Ramos EM; Dokuru DR; Van Berlo V; Wojta K; Wang Q; Huang AY; Miller ZA; Karydas AM; Bigio EH; Rogalski E; Weintraub S; Rader B; Miller BL; Gorno-Tempini ML; Mesulam MM; Coppola G
Alzheimers Dement; 2019 Apr; 15(4):553-560. PubMed ID: 30599136
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.
Kashyap SN; Boyle NR; Roberson ED
Neurotherapeutics; 2023 Jan; 20(1):140-153. PubMed ID: 36781744
[TBL] [Abstract][Full Text] [Related]
8. Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results.
Sevigny J; Uspenskaya O; Heckman LD; Wong LC; Hatch DA; Tewari A; Vandenberghe R; Irwin DJ; Saracino D; Le Ber I; Ahmed R; Rohrer JD; Boxer AL; Boland S; Sheehan P; Brandes A; Burstein SR; Shykind BM; Kamalakaran S; Daniels CW; David Litwack E; Mahoney E; Velaga J; McNamara I; Sondergaard P; Sajjad SA; Kobayashi YM; Abeliovich A; Hefti F
Nat Med; 2024 May; 30(5):1406-1415. PubMed ID: 38745011
[TBL] [Abstract][Full Text] [Related]
9. Case report: coexistence of C9orf72 expansion and progranulin mutation in a case of genetic frontotemporal dementia-clinical features and neuroimaging correlates.
Ghirelli A; Spinelli EG; Canu E; Domi T; Basaia S; Castelnovo V; Pozzi L; Magnani G; Caso F; Caroppo P; Prioni S; Villa C; Riva N; Quattrini A; Carrera P; Filippi M; Agosta F
J Neurol; 2023 Oct; 270(10):5102-5109. PubMed ID: 37382630
[No Abstract] [Full Text] [Related]
10. Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translation.
Aggarwal G; Banerjee S; Jones SA; Benchaar Y; Bélanger J; Sévigny M; Smith DM; Niehoff ML; Pavlack M; de Vera IMS; Petkau TL; Leavitt BR; Ling K; Jafar-Nejad P; Rigo F; Morley JE; Farr SA; Dutchak PA; Sephton CF; Nguyen AD
J Biol Chem; 2023 Dec; 299(12):105475. PubMed ID: 37981208
[TBL] [Abstract][Full Text] [Related]
11. GRN Mutations Are Associated with Lewy Body Dementia.
Reho P; Koga S; Shah Z; Chia R; ; ; Rademakers R; Dalgard CL; Boeve BF; Beach TG; Dickson DW; Ross OA; Scholz SW
Mov Disord; 2022 Sep; 37(9):1943-1948. PubMed ID: 35810449
[TBL] [Abstract][Full Text] [Related]
12. Dendritic spine head diameter is reduced in the prefrontal cortex of progranulin haploinsufficient mice.
Cook AK; Greathouse KM; Manuel PN; Cooper NH; Eberhardt JM; Freeman CD; Weber AJ; Herskowitz JH; Arrant AE
Mol Brain; 2024 Jun; 17(1):33. PubMed ID: 38840181
[TBL] [Abstract][Full Text] [Related]
13. Atypical White Matter Hyperintensities Markedly Impact Plasma Neurofilament Light Chain Variability in GRN Patients.
Vítor J; Saracino D; Ströer S; Camuzat A; Dorgham K; Clot F; Martin-Hardy P; Pasquier F; ; Le Ber I
J Alzheimers Dis; 2023; 94(4):1351-1360. PubMed ID: 37393503
[TBL] [Abstract][Full Text] [Related]
14. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience.
Sellami L; Rucheton B; Ben Younes I; Camuzat A; Saracino D; Rinaldi D; Epelbaum S; Azuar C; Levy R; Auriacombe S; Hannequin D; Pariente J; Barbier M; Boutoleau-Bretonnière C; Couratier P; Pasquier F; Deramecourt V; Sauvée M; Sarazin M; Lagarde J; Roué-Jagot C; Forlani S; Jornea L; David I; ; ; LeGuern E; Dubois B; Brice A; Clot F; Lamari F; Le Ber I
Neurobiol Aging; 2020 Jul; 91():167.e1-167.e9. PubMed ID: 32171590
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Swift IJ; Rademakers R; Finch N; Baker M; Ghidoni R; Benussi L; Binetti G; Rossi G; Synofzik M; Wilke C; Mengel D; Graff C; Takada LT; Sánchez-Valle R; Antonell A; Galimberti D; Fenoglio C; Serpente M; Arcaro M; Schreiber S; Vielhaber S; Arndt P; Santana I; Almeida MR; Moreno F; Barandiaran M; Gabilondo A; Stubert J; Gómez-Tortosa E; Agüero P; Sainz MJ; Gohda T; Murakoshi M; Kamei N; Kittel-Schneider S; Reif A; Weigl J; Jian J; Liu C; Serrero G; Greither T; Theil G; Lohmann E; Gazzina S; Bagnoli S; Coppola G; Bruni A; Quante M; Kiess W; Hiemisch A; Jurkutat A; Block MS; Carlson AM; Bråthen G; Sando SB; Grøntvedt GR; Lauridsen C; Heslegrave A; Heller C; Abel E; Gómez-Núñez A; Puey R; Arighi A; Rotondo E; Jiskoot LC; Meeter LHH; Durães J; Lima M; Tábuas-Pereira M; Lemos J; Boeve B; Petersen RC; Dickson DW; Graff-Radford NR; LeBer I; Sellami L; Lamari F; Clot F; Borroni B; Cantoni V; Rivolta J; Lleó A; Fortea J; Alcolea D; Illán-Gala I; Andres-Cerezo L; Van Damme P; Clarimon J; Steinacker P; Feneberg E; Otto M; van der Ende EL; van Swieten JC; Seelaar H; Zetterberg H; Sogorb-Esteve A; Rohrer JD
Alzheimers Res Ther; 2024 Mar; 16(1):66. PubMed ID: 38539243
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.
Zhou X; Kukar T; Rademakers R
Adv Exp Med Biol; 2021; 1281():219-242. PubMed ID: 33433878
[TBL] [Abstract][Full Text] [Related]
17. The missense p.Trp7Arg mutation in GRN gene leads to progranulin haploinsufficiency.
Saracino D; Sellami L; Clot F; Camuzat A; Lamari F; Rucheton B; Benyounes I; Roué-Jagot C; Lagarde J; Sarazin M; Jornea L; Forlani S; LeGuern E; Dubois B; Brice A; Le Ber I
Neurobiol Aging; 2020 Jan; 85():154.e9-154.e11. PubMed ID: 31262553
[TBL] [Abstract][Full Text] [Related]
18. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
[TBL] [Abstract][Full Text] [Related]
19. Rare exonic variant affects GRN splicing and contributes to frontotemporal lobar degeneration.
Wauters E; Gossye H; Frydas A; Sieben A; Van Broeckhoven C
Neurobiol Aging; 2023 Oct; 130():61-69. PubMed ID: 37459659
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
